SCHEMBL11306334

SCHEMBL11306334

O=C(NO)c1ccc(N(c2ccccc2)C2CCNC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 6/20 0.45
▸ HDAC6 Q9UBN7 5/20 0.45
▸ HDAC8 Q9BY41 4/20 0.45
▸ SLC6A2 P23975 8/20 0.44
▸ SLC6A4 P31645 8/20 0.44
▸ SLC6A3 Q01959 6/20 0.44
▸ KCNH2 Q12809 2/20 0.44
▸ HDAC3 O15379 2/20 0.44
▸ HDAC2 Q92769 2/20 0.44
▸ NCOR2 Q9Y618 2/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ IDO1 P14902 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ HDAC7 Q8WUI4 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CYP2D6 P10635 1/20 0.43
▸ HDAC4 P56524 1/20 0.42
▸ HDAC10 Q969S8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11300763 0.88 HDAC8 (0.42) HDAC8ALOX15KDM4EMEN1LMNA
SCHEMBL11301824 0.86 KDM4E (0.39) HDAC1HDAC6HDAC8SLC6A2SLC6A4
SCHEMBL11298741 0.84 SLC6A4 (0.45) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL11302583 0.84 SLC6A2 (0.53) HDAC1HDAC6HDAC8SLC6A2SLC6A4
SCHEMBL7343934 0.81 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL11300778 0.81 HDAC1 (0.49) HDAC1HDAC6HDAC8SLC6A2SLC6A4
SCHEMBL11028767 0.81 NR1H3 (0.47) HDAC1HDAC6HDAC8SLC6A2SLC6A4
SCHEMBL11304366 0.79 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3KCNH2CYP2D6
SCHEMBL6826483 0.79 OPRD1 (0.67) OPRM1OPRD1
SCHEMBL11297190 0.78 HDAC6 (0.44) HDAC1HDAC6HDAC8HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback